CD8A and lung cancer: Importantly, lung cancer patients with high infiltrating Rab37+/PD-1+/TIM3+ CD8+ T cells showed poor prognosis, suggesting that these tumor-infiltrating T cells are likely terminal exhaustion T cells with reduced proliferation and poor responses to immunotherapy.